Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2788)	4/23/2010 12:26:45 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

ABIO is having another good spike today.<g> The stock was up 46.73% and is still up 33.66% with volume > 6M >4.5x its ADV bigcharts.marketwatch.com ABIO was able to significantly trim its loss last Yr. to $3.87 from $25.72 in 2008 it has no significant LTD and the insiders hold a good % of the stock. The stock isn't completely off from the DT coming from its Dec2006 H at $419 <g> bigcharts.marketwatch.com And of course, the Fdeb 2000 H above the $8000 levelis too far away.<g> bigcharts.marketwatch.com Bernard

To: Jibacoa who wrote (2788)	6/11/2010 1:06:32 PM
From: Jibacoa	Respond to of 3722

NMTI is trying to get to its resistance at the $3 level.<g> The stock is up 6.43% on volume of 28Ks still < half its ADV bigcharts.marketwatch.com NMTI announced on Tuesday at EuroPCR 2010 that it launched its RT2 Delivery System,considered a pivotal breakthrough in septal implant delivery. The RT2 Delivery System is a rapid transport enhancement that is pre-attached to NMTI’s BioSTAR and STARFlex implants, and is designed to allow physicians to easily set the implant to conform to a patient’s individual anatomy and avoid septal distortion and unnecessary repositioning. The RT2 Delivery System is available in France and NMTI expects to launch the system in countries throughout Europe over the next several months. As mentioned, NMTI still has 4Qs of lower revenues and the loss on the 1stQ was significantly higher than in 2009. The stock is trying to get off from its long term DT coming from its Feb2006 H at $25.96 <g> The ACTAY is $3 But in spite of the larger losses and lower revenues, since NMTI has no significant LTD, it seems that with some good news and a close above $3 the stock could get to test the $5 level.<g> bigcharts.marketwatch.com Bernard